OLR1 and androgen insensitivity syndrome: In univariate logistic regression analysis, the concentration of serum sLOX‐1 was associated with a poor long‐term outcome in AIS patients with an unadjusted OR of 2.441 (95% CI, 1.695–3.571, p < .001).